Pharmaceuticals
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.
Europe, Israel, and the medical record of a nation - opinion
How Evogene is changing the future for the pharma and agriculture markets
Taking too many medications may harm older adults, study warns
Israeli medical cannabis company receives European export certification
The EU-GMP certification is essential in order to create, export and market any type of medicine in Europe, including medical cannabis.
Major Australian pharma company considers entering Israeli market
Australian pharma giant Chemist Warehouse is in the advanced stages of considering expansion into the Israeli market.
CVS, Walmart, Walgreens ordered to pay $650.6m. in Ohio in opioid case
The litigation has resulted in several nationwide settlements, including a $4.25 billion settlement with Israel-based Teva Pharmaceutical Industries
Forget avocado oil, this startup uses a new avo extract to treat skin issues
Early startup AvoMed has developed a way to use the whole buffalo (or in this case, the whole avocado) to develop effective skin damage treatments.
Pfizer profit beats estimates on higher demand for COVID products
Revenue from the antiviral pill, Paxlovid, exceeded market estimates by more than $1b, while vaccine sales surged 20%, helping the drugmaker reaffirm the combined 2022 revenue forecast of $54b.
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits
The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.
For its redemption, the pharmaceutical industry must go plant-based
Should the pharmaceutical industry be lauded or lambasted for the drugs that they've developed? Or is there a middle path for the industry to take?
Science breakthroughs in space: Israel leads the way
SpacePharma founder Yossi Yamin talks science in no gravity.
CytoReason forms partnership with Helixrus, expanding into Asia
The partnership will see Helixrus represent CytoReason’s AI platform and professional services in the Korean market.
Eight Israeli start-ups to form international collaborations
Following BetterPlayBio’s program, C2i Genomic, Nucle.ai, Medial Earlysign, iBex, Octopus, Imagene, Itamar Medical and iCardio are ready to hit the global market.
